Skip to content
Screener

Harrow HROW Operating Cash Flow

Operating Cash Flow at other companies

AbbVie logo
AbbVieABBV
$3.83B+134%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$7.41M+254%
Bausch + Lomb logo
Bausch + LombBLCO
$153M+337%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$65.99M-47.7%
Opko Health logo
Opko HealthOPK
-$43.5M+47.9%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$230M+9.0%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.49B+22.8%
Enterprise value$1.7B+5.6%
P/S5.5×+0.2×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Harrow’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-022254
Line item2026 / For the Three Months Ended March 31,2025 / For the Three Months Ended March 31,
Accounts payable, accrued expenses, accrued rebates and copay assistance3,377,000(11,096,000)
Accrued payroll and related liabilities(1,201,000)(1,891,000)
Deferred revenue and customer deposits(639,000)101,000
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES(8,992,000)19,668,000
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in patent and trademark assets(9,000)(42,000)
Purchase of product rights(18,000,000)-
Purchases of property, plant and equipment(194,000)(170,000)

Item 1. Financial Statements (unaudited) Item

FAQ

What is Harrow's operating cash flow?
Harrow (HROW) reported operating cash flow of -$8.99M in Q1 2026.
How has Harrow's operating cash flow changed year-over-year?
Harrow's operating cash flow decreased by 145.7% year-over-year, from $19.67M to -$8.99M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Harrow's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude